Pure Biologics Spólka Akcyjna
PUR.WA · WSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | PLN 5 | PLN 8 | PLN 6 | PLN 10 |
| Gross Profit | -PLN 5 | -PLN 8 | -PLN 6 | -PLN 283 |
| % Margin | – | – | – | – |
| R&D Expenses | PLN 717 | PLN 2,181 | PLN 0 | PLN 0 |
| G&A Expenses | PLN 244 | PLN 0 | PLN 417 | PLN 1,379 |
| SG&A Expenses | PLN 244 | PLN 3,125 | PLN 417 | PLN 1,379 |
| Sales & Mktg Exp. | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Other Operating Expenses | -PLN 62 | -PLN 2,613 | PLN 377 | PLN 5,485 |
| Operating Expenses | PLN 899 | PLN 2,693 | PLN 794 | PLN 6,864 |
| Operating Income | -PLN 904 | -PLN 2,701 | -PLN 800 | -PLN 6,874 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -PLN 393 | -PLN 321 | -PLN 295 | -PLN 385 |
| Pre-Tax Income | -PLN 1,297 | -PLN 3,022 | -PLN 1,095 | -PLN 7,259 |
| Tax Expense | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Net Income | -PLN 1,215 | -PLN 4,719 | -PLN 1,338 | -PLN 10,656 |
| % Margin | – | – | – | – |
| EPS | -0.21 | -0.74 | -0.34 | -1.94 |
| % Growth | 71.6% | -117.6% | 82.5% | – |
| EPS Diluted | -0.21 | -0.74 | -0.34 | -1.94 |
| Weighted Avg Shares Out | 5,665 | 6,380 | 5,135 | 5,503 |
| Weighted Avg Shares Out Dil | 7,759 | 4,086 | 3,954 | 3,751 |
| Supplemental Information | – | – | – | – |
| Interest Income | PLN 0 | PLN 30 | PLN 0 | PLN 0 |
| Interest Expense | PLN 393 | PLN 471 | PLN 299 | PLN 381 |
| Depreciation & Amortization | PLN 54 | PLN 35 | PLN 54 | PLN 72 |
| EBITDA | -PLN 850 | -PLN 2,234 | -PLN 742 | -PLN 6,806 |
| % Margin | – | – | – | – |